Results 81 to 90 of about 548,741 (210)

Anti‐HLA‐B7 / HLA‐B44 strong cross immunoreactivity observed in flow cytometry HLA‐B27 immunotyping

open access: yes
International audienceAbstract Cross reactivities are known for human leukocyte antigen inside HLA‐B7 related Cross‐Reactive Group (B7CREG). Some CE‐IVD flow‐cytometry kits use double monoclonal antibodies (mAb) to distinguish HLA‐B27 and HLA‐B7 but ...
Waeckel, Louis   +3 more
core   +1 more source

HLA-B27 subtypes in the spondarthropathies

open access: yes, 1993
SUMMARY The spondartliropathy (Sp)-associated HLA-B27 antigen includes al least seven subtypes. B*2701–07, of which 01, 02, 05 and 07 occur in Caucasians. This study examined the B27 subtype distribution in British patients with Sp.
I L MACLEAN   +6 more
core   +1 more source

Clinical Images: Skeletal fluorosis presenting with diffuse periostitis and polyarticular synovitis

open access: yes
Arthritis &Rheumatology, Volume 78, Issue 9, Page 2001-2001, September 2026.
Mitali Sen
wiley   +1 more source

Genotype counts and (%) of rs61752717 in HLA-B27-positive and HLA-B27-negative Turkish cohorts (including four HLA-B27-negative subjects with co-existent AS and FMF, three homozygous for rs61752717 ‘C’ allele, one homozygote for rs61752717 ‘T’ allele).

open access: yes, 2019
Genotype counts and (%) of rs61752717 in HLA-B27-positive and HLA-B27-negative Turkish cohorts (including four HLA-B27-negative subjects with co-existent AS and FMF, three homozygous for rs61752717 ‘C’ allele, one homozygote for rs61752717 ‘T’ allele).
Fernur Çapa (6556490)   +29 more
core   +1 more source

HLA B27 y las espondilartropatías seronegativas

open access: yesRevista Cubana de Medicina, 1997
Se realizó el tipaje serológico para el antígeno HLA B27 a 19 pacientes con espondilartropatías seronegativas para conocer su relación y, de ellos, 6 resultaron positivos; 94 individuos sanos conformaron el grupo control y en 4 se encontró el antígeno ...
Modesto González Cortiñas   +3 more
doaj  

Genotype counts and (%) of rs61752717 in HLA-B27-positive and HLA-B27-negative combined cohorts (including four HLA-B27-negative subjects with co-existent AS and FMF, three homozygous for rs61752717 ‘C’ allele, one homozygote for rs61752717 ‘T’ allele).

open access: yes, 2019
Genotype counts and (%) of rs61752717 in HLA-B27-positive and HLA-B27-negative combined cohorts (including four HLA-B27-negative subjects with co-existent AS and FMF, three homozygous for rs61752717 ‘C’ allele, one homozygote for rs61752717 ‘T’ allele).
Fernur Çapa (6556490)   +29 more
core   +1 more source

Epidemiologic and ophthalmologic characteristics of patients with HLA-B27-associated uveitis.

open access: yes, 2020
Epidemiologic and ophthalmologic characteristics of patients with HLA-B27-associated uveitis.
Pierre Pradat (816487)   +6 more
core   +1 more source

强直性脊柱炎患者HLA-B27、CRP和ESR的水平及相关性分析

open access: yesZhongguo shiyan zhenduanxue, 2013
目的探讨强直性脊柱炎(AS)患者HLA-B27、CRP和ESR的水平及相关性。方法检测对54例AS患者和48例健康对照者人类白细胞抗原B27(Human leucocyte antigen B27,HLA-B27)血沉(ESR)、C反应蛋白(CRP)的水平,比较HLA-B27、CRP和ESR在AS的阳性率,探讨三者对AS诊断的相关性。结果 HLA-B27、CRP和ESR在AS患者阳性率分别为90.7%、85.1%、72.2%;AS患者和健康对照组HLA-B27、CRP和ESR的水平存在显著性差异 ...
祝文彩   +3 more
doaj  

Mydriasis as a Secondary Effect in Patients With HLA‐B27–Associated Uveitis

open access: yesMedicine Advances
Acute anterior uveitis (AAU) is the most common form of uveitis, and approximately 90% of AAU cases are associated with human leukocyte antigen (HLA)‐B27.
Saim Mahmood Khan   +6 more
doaj   +1 more source

Clinical Characteristics of Patients with Spondyloarthritides and HLA-B27 Positive Antigen

open access: yesCollegium antropologicum, 2011
The aim of this study was to present our experiences in diagnosing spondyloarthritides (SpA), and to list the most common clinical features of HLA-B27 positive patients. The study included 65 HLA-B27 positive patients with confirmed diagnosis of ankylosing spondylitis (AS) and psoriatic arthritis (PsA) who were analyzed between 2009 and 2010 in Clinic ...
Glasnović, Marija   +12 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy